Back to Screener

Healthcare

Wesana Health Holdings Inc.(WSNAF)

Live Price

Offline

$0.0163

+0.00% today

1Y Change

-35.57%

Window

Jun 20, 2025 โ†’ Jun 18, 2026

Market Cap
โ€”
Revenue Growth
0.0%
EPS Growth
+79.1%
Dividend Yield
0.0%

Coverage: 252 bars ยท Jun 20, 2025 โ†’ Jun 18, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Wesana Health Holdings Inc. (WSNAF) is a Healthcare stock with listed on OTC. The stock last traded around $0.02 and down 35.6% across the available one-year price window (Jun 20, 2025 โ†’ Jun 18, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of +79.1%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS +79.1%, free cash flow +88.7% with operating margin 0.0% and ROIC 4706.5%. Stock Foundry combines WSNAF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Comparison

Normalized Performance vs SPY

Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.

1Y shared range

WSNAF

โ€”

Normalized return

SPY

โ€”

S&P 500

Excess Return

โ€”

Relative to SPY

WSNAF Max Drawdown

-90.36%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for WSNAF and SPY.

Calendar-year return history is still loading or unavailable.

EPS Consensus

-0.06

Range -0.06 โ†’ -0.06

No analyst count

vs prior: -20.0%

Revenue Outlook

$0.0B

Range $0.0B โ†’ $0.0B

No analyst count

Consensus Spread

EPS spread0.0%
Revenue spreadโ€”

Lower spread suggests tighter agreement across covering analysts.

Trend

EPS trend

Consensus average across visible periods

-0.06
Latest visible period
Q4 2026Q1 2028
6 visible pointstrend: -20.0%

Trend

Revenue trend

Average analyst revenue estimate

$0.0B
Latest visible period
Q4 2026Q1 2028
6 visible points

Timeline

Analyst forecast ladder

Sorted by period end date. Includes both cached rows and live fallbacks from FMP.

Q1 2028
Ends Mar 30, 2028
quarter
Revenue
$0.0B
$0.0B to $0.0B
EPS
-0.06
-0.06 to -0.06
No analyst count
EPS: No analyst count
May 3, 09:30 AM UTC
stable/analyst-estimates
Q4 2027
Ends Dec 30, 2027
quarter
Revenue
$0.0B
$0.0B to $0.0B
EPS
-0.05
-0.05 to -0.05
No analyst count
EPS: No analyst count
May 3, 09:30 AM UTC
stable/analyst-estimates
Q3 2027
Ends Sep 30, 2027
quarter
Revenue
$0.0B
$0.0B to $0.0B
EPS
-0.04
-0.04 to -0.04
No analyst count
EPS: No analyst count
May 3, 09:30 AM UTC
stable/analyst-estimates
Q2 2027
Ends Jun 30, 2027
quarter
Revenue
$0.0B
$0.0B to $0.0B
EPS
-0.02
-0.02 to -0.02
No analyst count
EPS: No analyst count
May 3, 09:30 AM UTC
stable/analyst-estimates
Q1 2027
Ends Mar 30, 2027
quarter
Revenue
$0.0B
$0.0B to $0.0B
EPS
-0.04
-0.04 to -0.04
No analyst count
EPS: No analyst count
May 3, 09:30 AM UTC
stable/analyst-estimates
Q4 2026
Ends Dec 30, 2026
quarter
Revenue
$0.0B
$0.0B to $0.0B
EPS
-0.07
-0.07 to -0.07
No analyst count
EPS: No analyst count
May 3, 09:30 AM UTC
stable/analyst-estimates

Next Step

Put consensus data in context

Forecasts are most valuable when they sit beside comparisons, earnings setup, and the rest of the business story.